Modification of adrenaline mydriasis by agents acting on sulphydryl groups.
D000818:Animals; D002729:Chloromercuribenzoates / Q000494:pharmacology; D004837:Epinephrine / Q000037:antagonists & inhibitors*; D009184:Mydriatics / Q000037:antagonists & inhibitors*; D010396:Penicillamine / Q000494:pharmacology; D011680:Pupil / Q000187:drug effects; D011817:Rabbits; D013439:Sulfhydryl Reagents / Q000494:pharmacology*; D013997:Time Factors; D020245:p-Chloromercuribenzoic Acid
D002729:Chloromercuribenzoates; D009184:Mydriatics; D013439:Sulfhydryl Reagents; D020245:p-Chloromercuribenzoic Acid; D010396:Penicillamine; D004837:Epinephrine